NEW YORK (GenomeWeb News) – Molecular diagnostics is gaining traction among clinicians and were the second-most popular type of test performed in the second quarter, according to a survey released today by investment bank Mizuho Securities.

In the survey of 262 physicians and laboratory personnel for clues about trends in clinical labs, Mizuho found that molecular testing made up 25 percent of all tests performed during the second quarter of this year, trailing only immunochemical tests, which made up 36 percent of all test conducted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.